These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
149 related articles for article (PubMed ID: 17136880)
1. Three suitable antigens for delayed-type hypersensitivity skin testing in a tropical country like Thailand. Siripassorn K; Charoenwongse P; Ruxrungtham K Asian Pac J Allergy Immunol; 2006; 24(2-3):143-52. PubMed ID: 17136880 [TBL] [Abstract][Full Text] [Related]
2. Delayed hypersensitivity skin testing in the Thai adult population. Thongngarm T; Valyasevi AM; Pattanapanyasat K; Udompunturak S J Med Assoc Thai; 2006 Nov; 89 Suppl 5():S195-200. PubMed ID: 17718262 [TBL] [Abstract][Full Text] [Related]
3. Use of tetanus toxoid for testing cell-mediated immunity. Whittingham S; Feery B; Mackay IR Aust N Z J Med; 1982 Oct; 12(5):511-4. PubMed ID: 6758748 [TBL] [Abstract][Full Text] [Related]
4. Delayed cutaneous hypersensitivity in normals: choice of antigens and comparison to in vitro assays of cell-mediated immunity. Gordon EH; Krouse HA; Kinney JL; Stiehm ER; Klaustermeyer WB J Allergy Clin Immunol; 1983 Nov; 72(5 Pt 1):487-94. PubMed ID: 6355249 [TBL] [Abstract][Full Text] [Related]
5. Tetanus toxoid as an antigen for delayed cutaneous hypersensitivity. Delafuente JC; Eisenberg JD; Hoelzer DR; Slavin RG JAMA; 1983 Jun; 249(23):3209-11. PubMed ID: 6343648 [TBL] [Abstract][Full Text] [Related]
7. Cynomolgus monkeys (Macaca fascicularis) in preclinical immune function safety testing: development of a delayed-type hypersensitivity procedure. Bleavins MR; de la Iglesia FA Toxicology; 1995 Jan; 95(1-3):103-12. PubMed ID: 7825177 [TBL] [Abstract][Full Text] [Related]
8. Analysis of cutaneous delayed-type hypersensitivity reaction and T cell proliferative response in elderly nursing home patients: an approach to identifying immunodeficient patients. Castle SC; Norman DC; Perls TT; Chang MP; Yoshikawa TT; Makinodan T Gerontology; 1990; 36(4):217-29. PubMed ID: 2272525 [TBL] [Abstract][Full Text] [Related]
9. Enhanced delayed hypersensitivity skin test reactivity with serial testing in healthy volunteers. Keystone EC; Demerieux P; Gladman D; Poplonski L; Piper S; Buchanan R Clin Exp Immunol; 1980 Apr; 40(1):202-5. PubMed ID: 6993077 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of bovine cutaneous delayed-type hypersensitivity (DTH) to various test antigens and a mitogen using several adjuvants. Hernández A; Yager JA; Wilkie BN; Leslie KE; Mallard BA Vet Immunol Immunopathol; 2005 Mar; 104(1-2):45-58. PubMed ID: 15661330 [TBL] [Abstract][Full Text] [Related]
11. Selection of skin test antigens to evaluate PPD anergy. Wright PW; Crutcher JE; Holiday DB J Fam Pract; 1995 Jul; 41(1):59-64. PubMed ID: 7798066 [TBL] [Abstract][Full Text] [Related]
12. Instability of delayed-type hypersensitivity skin test anergy in human immunodeficiency virus infection. Caiaffa WT; Graham NM; Galai N; Rizzo RT; Nelson KE; Vlahov D Arch Intern Med; 1995 Oct; 155(19):2111-7. PubMed ID: 7575072 [TBL] [Abstract][Full Text] [Related]
13. Purified protein derivative tuberculin and delayed-type hypersensitivity skin testing in migrant farm workers at risk for tuberculosis and HIV coinfection. Villarino ME; Geiter LJ; Schulte JM; Castro KG AIDS; 1994 Apr; 8(4):477-81. PubMed ID: 8011250 [TBL] [Abstract][Full Text] [Related]
14. The effect of immunodeficiency on cutaneous delayed-type hypersensitivity testing in HIV-infected women without anergy: implications for tuberculin testing. HER Study Group. HIV Epidemiology Research. Klein RS; Flanigan T; Schuman P; Smith D; Vlahov D Int J Tuberc Lung Dis; 1999 Aug; 3(8):681-8. PubMed ID: 10460100 [TBL] [Abstract][Full Text] [Related]
15. Performance of antigens used in detecting delayed-type hypersensitivity in adolescents infected with the human immunodeficiency virus. Rogers AS; Ellenberg JH; Douglas SD; Henry-Reid L; Peralta L; Wilson CM; Clin Diagn Lab Immunol; 2001 Mar; 8(2):273-8. PubMed ID: 11238207 [TBL] [Abstract][Full Text] [Related]
16. Validation of a Candida albicans delayed-type hypersensitivity (DTH) model in female juvenile rats for use in immunotoxicity assessments. Collinge M; Thorn M; Peachee V; White K J Immunotoxicol; 2013; 10(4):341-8. PubMed ID: 23282408 [TBL] [Abstract][Full Text] [Related]
17. Immunization responses in rheumatoid arthritis patients treated with rituximab: results from a controlled clinical trial. Bingham CO; Looney RJ; Deodhar A; Halsey N; Greenwald M; Codding C; Trzaskoma B; Martin F; Agarwal S; Kelman A Arthritis Rheum; 2010 Jan; 62(1):64-74. PubMed ID: 20039397 [TBL] [Abstract][Full Text] [Related]
18. The use of tetanus toxoid to elucidate the delayed-type hypersensitivity response in an older, immunized population. French AL; McCullough ME; Rice KT; Schultz ME; Gordin FM Gerontology; 1998; 44(1):56-60. PubMed ID: 9436017 [TBL] [Abstract][Full Text] [Related]
19. Pediatric case series evaluating a standardized Candida albicans skin test product. Ohri LK; Manley JM; Chatterjee A; Cornish NE Ann Pharmacother; 2004 Jun; 38(6):973-7. PubMed ID: 15084686 [TBL] [Abstract][Full Text] [Related]
20. Comparison of two methods for the assessment of delayed-type hypersensitivity skin responses in patients with human immunodeficiency virus infection. Martínez-Marcos FJ; López-Cortés LF; Pachón J; Alarcón A; Cordero E; Viciana P Clin Infect Dis; 1998 Jun; 26(6):1330-4. PubMed ID: 9636858 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]